Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 2.960
-0.030 (-1.00%)
May 21, 2026, 1:00 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 204.67 million as of May 21, 2026. Its market cap has decreased by -41.59% in one year.
Market Cap
204.67M
Enterprise Value
186.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.96
Market Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 204.67M, an increase of 306.37%. That is a compound annual growth rate of 16.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 204.67M | 1.01% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 230.75M |
| Xbrane Biopharma AB | 227.69M |
| Xintela AB | 215.32M |
| Active Biotech AB | 206.93M |
| Diamyd Medical AB | 185.36M |
| Nanologica AB | 164.38M |
| AlzeCure Pharma AB | 160.31M |
| Elicera Therapeutics AB | 147.31M |